Can Amgen's new-and-improved Kyprolis kick-start myeloma sales? by Carly Helfand Friday, August 31, 2018 Amgen's Kyprolis has struggled to live up to expectations for years, but it’s hoping new, more convenient dosing will help do the trick.
